Recent Zambian research into the antiretroviral (ARV) drug, nevirapine, has found that it does not compromise the long-term health of women, contradicting earlier studies conducted in Uganda. Nevirapine is widely used in Africa to prevent mother-to-child HIV transmission. A single dose of nevirapine is given to the mother before birth and to her baby after birth.
Links
[1] https://www.pambazuka.org/author/contributor
[2] https://www.pambazuka.org/taxonomy/term/3286
[3] https://www.pambazuka.org/article-issue/269
[4] https://www.pambazuka.org/category/ict-media-security
[5] http://www.pambazuka.org/en/category.php/hivaids/37022
[6] https://www.pambazuka.org/taxonomy/term/3297